Linezolid for multidrug-resistant tuberculosis: How should we approach it?

被引：9
|
作者：
Santin, Miguel [1 ]
机构：
[1] Bellvitge Univ Hosp IDIBELL, Infect Dis Serv, Unit TB, Barcelona, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2016年 / 34卷 / 02期
关键词：
XDR-TB; EFFICACY; DRUG; TOLERABILITY; SAFETY;
D O I：
10.1016/j.eimc.2015.12.002
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [1] Linezolid for multidrug-resistant tuberculosis
    Chang, Kwok-Chiu
    Leung, Chi-Chiu
    Daley, Charles L.
    LANCET INFECTIOUS DISEASES, 2012, 12 (07) : 502 - 503
  • [2] Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
    Schecter, G. F.
    Scott, C.
    True, L.
    Raftery, A.
    Flood, J.
    Mase, S.
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) : 49 - 55
  • [3] Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study
    Bolhuis, Mathieu S.
    Tiberi, Simon
    Sotgiu, Giovanni
    De Lorenzo, Saverio
    Kosterink, Jos G. W.
    van der Werf', Tjip S.
    Miglioris, Giovanni Battista
    Alffenaar, Jan-Willem C.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 1205 - 1207
  • [4] Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
    Mase, Anjeli
    Lowenthal, Phil
    True, Lisa
    Henry, Leslie
    Barry, Pennan
    Flood, Jennifer
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (12):
  • [5] Linezolid for multidrug-resistant tuberculosis reply
    Chang, Kwok-Chiu
    Leung, Chi-Chiu
    Daley, Charles L.
    LANCET INFECTIOUS DISEASES, 2013, 13 (01) : 16 - 17
  • [6] Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients
    Bolhuis, Mathieu S.
    van Altena, Richard
    van Soolingen, Dick
    de Lange, Wiel C. M.
    Uges, Donald R. A.
    van der Werf, Tjip S.
    Kosterink, Jos G. W.
    Alffenaar, Jan-Willem C.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1614 - 1621
  • [7] Linezolid Pharmacokinetics/Pharmacodynamics-Based Optimal Dosing for Multidrug-Resistant Tuberculosis
    Zhou, Wenqiang
    Nie, Wenjuan
    Wang, Qingfeng
    Shi, Wenhui
    Yang, Yang
    Li, Qi
    Zhu, Hui
    Liu, Zhongquan
    Ding, Yangming
    Lu, Yu
    Chu, Naihui
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 59 (06)
  • [8] Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China Comment
    Zhang, Peize
    Tan, Jie
    Lin, Yi
    Zhang, Hailin
    Deng, Guofang
    Chen, Xiaoyou
    DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (02) : 96 - 98
  • [9] Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment
    Eimer, Johannes
    Frechet-Jachym, Mathilde
    Le Du, Damien
    Caumes, Eric
    El-Helali, Najoua
    Marigot-Outtandy, Dhiba
    Mechai, Frederic
    Peytavin, Gilles
    Pourcher, Valerie
    Rioux, Christophe
    Yazdanpanah, Yazdan
    Robert, Jerome
    Guglielmetti, Lorenzo
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E947 - E956
  • [10] Bedaquiline and linezolid regimens for multidrug-resistant tuberculosis: a systematic review and meta-analysis
    Cheraghi, Mahdis
    Amiri, Mehrnaz
    Andarzgoo, Sahar
    Zarei, Fatemeh
    Seghatoleslami, Zahra Sadat
    Centis, Rosella
    Visca, Dina
    D'Ambrosio, Lia
    Pontali, Emanuele
    Nasiri, Mohammad Javad
    Migliori, Giovanni Battista
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2025, 51 (01)
12345